Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Enzo Biochem IncENZ-1.941.590.90-0.49-14.59%-27.12%57.75$1.12$0.005,324$0.99

Detail of Enzo Biochem Inc

 
CEO
Ms. Kara Cannon
Employees
125
Industry
Diagnostics & Research
Sector
Healthcare
Market cap
$51M

Company details

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
NI
Revenue (Rev)
$31.91M
Cost of goods (CoG)
-$17.28M
Gross profit (GP)
$14.63M
Operating expense (OE)
-$27.00M
Research and development (R&D)
-$2.64M
General and administrative (G&A)
-$24.36M
Operating income (OI)
-$12.37M
Other income expense (OIE)
-$791,000.00
Pretax income (PI)
-$9.82M
Net income (NI)
-$26.08M
Enzo Biochem Inc
ENZ • XNYS • US
$0.99
-0.39 (-28.26%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Dividend yield
10.10%
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$0.51
Margin profit
-81.73%
52 week low
$0.9602
52 week high
$1.50
50-day simple moving average
$1.09
200-day simple moving average
$1.12
Percent held by insiders
21.57%
Percent held by institutions
31.79%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ENZ -27.74%
eps change
ENZ 0.00%